降钙素原的检测和应用——《感染相关生物标志物临床意义解读专家共识》解读(5)
[23] Woodhead M， Blasi F， Ewig S， et al. Guidelines for the management of adult lower respiratory tract infections — full version [J]. Clin Microbiol Infect， 2011， 17(Suppl 6)： E1-E59.
[24] Bishop BM， Bon JJ， Trienski TL， et al. Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit [J]. Ann Pharmacother， 2014， 48(5)： 577-583.
[25] Stolz D， Smyrnios N， Eggimann P， et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia： a randomised study [J]. Eur Respir J， 2009， 34(6)： 1364-1375.
[26] Bouadma L， Luyt CE， Tubach F， et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units(PRORATA trial)： a multicentre randomised controlled trial[J]. Lancet， 2010， 375(9713)： 463-474.
[27] Kalil AC， Metersky ML， Klompas M， et al. Management of adults with hospital-acquired and ventilator-associated pneumonia： 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society [J]. Clin Infect Dis， 2016， 63(5)： e61-e111., 百拇医药(朱美英 曹鄂洪)
[24] Bishop BM， Bon JJ， Trienski TL， et al. Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit [J]. Ann Pharmacother， 2014， 48(5)： 577-583.
[25] Stolz D， Smyrnios N， Eggimann P， et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia： a randomised study [J]. Eur Respir J， 2009， 34(6)： 1364-1375.
[26] Bouadma L， Luyt CE， Tubach F， et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units(PRORATA trial)： a multicentre randomised controlled trial[J]. Lancet， 2010， 375(9713)： 463-474.
[27] Kalil AC， Metersky ML， Klompas M， et al. Management of adults with hospital-acquired and ventilator-associated pneumonia： 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society [J]. Clin Infect Dis， 2016， 63(5)： e61-e111., 百拇医药(朱美英 曹鄂洪)